Dermatology Times Recaps Expert Interviews in June
Dermatology Times recaps its top expert interviews from June, covering a range of topics from psoriasis therapies, alopecia areata, seborrheic dermatitis, JAK inhibitors, rare conditions, boxed warnings, and more.
New Generation of Oral Psoriasis Therapies to Enhance Patient Quality of Life
Ben Lockshin, MD, FAAD, delves into the new generation of oral psoriasis therapies that work by targeting specific molecules in the immune system to enhance patient quality of life. The treatment has shown great promise in clinical trials and could be a revolutionary new way to treat psoriasis.
Current Treatment Landscape and Role of Oral Minoxidil in Alopecia Areata
James Song, MD, discusses the current treatment landscape for alopecia areata, genetic and immunological influences, and the role of oral minoxidil in the treatment of this condition. The article provides a comprehensive overview of the topic for clinicians treating patients with alopecia areata.
Challenges, Solutions, and Further Research Needed to Treat Seborrheic Dermatitis
Raj Chovatiya, MD, PhD, takes a deep dive into the challenges, solutions, and further research needed to treat seborrheic dermatitis, a common skin condition that affects millions of people worldwide. The article covers a range of topics, from the underlying causes of the condition to the best treatment options currently available.
Clinical Use and Safety Profiles for Effective Patient Communication of JAK Inhibitors
Raj Chovatiya, MD, PhD, discusses the clinical use and safety profiles of JAK inhibitors, a promising new class of drugs that work by targeting specific molecules involved in inflammation. The article is a must-read for any clinician looking to understand the latest advancements in this field.
Overview of Rare Conditions for Clinicians
Jason Hawkes, MD, MS, provides an overview of rare conditions for clinicians, offering an in-depth look at different conditions and their treatment options. The article is particularly useful for clinicians who may not see these conditions often but need to be prepared to treat them in patients.
Current Challenges in AD Treatment Landscape and Comparison of Biologics
James Song, MD, addresses current challenges in the atopic dermatitis (AD) treatment landscape and compares biologics currently available. The article provides a comprehensive overview of the current state of AD treatment for clinicians.
Unique Cases Highlighted by Double-Board Certified Pediatric and Cosmetic Dermatologist
Karan Lal, DO, MS, FAAD, shares what he learned from five unique patient cases this year. The article provides valuable insights into the world of pediatric and cosmetic dermatology and highlights the importance of tailoring treatment to each individual patient.
Boxed Warning Pros and Cons and Research Addressing Several Boxed Warnings
Jason Hawkes, MD, MS, breaks down boxed warnings for clinicians, offering a comprehensive look at the pros and cons of different boxed warnings and research addressing them. The article is a must-read for any clinician looking to understand the latest regulatory developments in the field.
Approach to Continuing Biologic Therapies into Pregnancy With Informed Timing Adjustments
Ben Lockshin, MD, FAAD, shares his approach to continuing biologic therapies into pregnancy with informed timing adjustments. The article is particularly useful for clinicians treating patients with psoriasis who may be considering becoming pregnant.
Combination Treatment Efficacy and Addressing Comorbidities to Improve Patient Safety
James Song, MD, explains combination treatment efficacy, addresses comorbidities, and provides pearls to improve patient safety. The article is a must-read for any clinician looking to optimize treatment for their patients with alopecia areata or other skin conditions.
Association of Kinases With Different Cytokine Receptors and Biological Functions
Jason Hawkes, MD, MS, details each of the kinases’ association with different cytokine receptors and biological functions. The article provides valuable insights into the molecular mechanisms involved in skin conditions and offers clinicians a deeper understanding of the disease processes.
The Evolving Role of AI in Dermatology
Zabinski, vice president and head of commercial strategy and AI at OM1, discusses the evolving role of AI in dermatology, focusing on its potential and challenges in skin cancer detection. The article offers a fascinating look at the intersection of technology and medicine.
Key Findings and Areas of Improvement for HS Treatment
Henry Lim, MD, discusses key findings and areas of improvement identified by the report, as well as his hopes for HS treatment moving forward. The article offers valuable insights into the latest advancements in HS treatment and highlights areas where further research is needed.
Data on Efficacy of On- and Off-Label Therapeutics for Vitiligo
Nanette Silverberg, MD, shares data on the efficacy of on- and off-label therapeutics for vitiligo, as well as the importance of communication with patients to promote clinical excellence. The article is a must-read for any clinician treating patients with vitiligo.
Tips for Effectively Treating Atopic Dermatitis Without Worsening Autoimmune Comorbidities
Jonathan Silverberg, MD, PhD, MPH, presents his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities. The article is particularly useful for clinicians who are treating patients with both atopic dermatitis and other autoimmune conditions.
Benefits of Combination Therapy for Vitiligo With Topicals and Devices
Karan Lal, DO, dives into the benefits of combination therapy for vitiligo with topicals and devices. The article offers clinicians a deeper understanding of the different treatment options available for vitiligo and how to best tailor treatment to individual patients.
Various Types of Therapeutics Available and Coming Soon for Pediatric Atopic Dermatitis
Amy Paller, MD, reviews the various types of therapeutics available and coming soon for pediatric atopic dermatitis and how she decides what treatment approach is best for each patient. The article is particularly useful for clinicians who are treating pediatric patients with AD and want to understand the latest treatment options available.
Similarities and Differences Between AAD’s Recent Atopic Dermatitis Guidelines and Other Guidelines
Robert Sidbury, MD, MPH, addresses the similarities and differences between the AAD’s recent atopic dermatitis guidelines and other guidelines from various groups and countries. The article is a must-read for any clinician looking to understand the latest developments in AD treatment and management.
New Biologics for Atopic Dermatitis That Target IL-22, IL-33, and OX40
Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more. The article offers a valuable look at the latest advancements in biologic therapy for AD.
Key Points from Phase 3 Data of Ruxolitinib for Vitiligo and STAT Pathway Targeting in Upcoming Atopic Dermatitis Therapeutics
David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics. The article offers a fascinating look at the cutting-edge research being conducted in the field of dermatology.
How Approved AD Therapeutics Currently Address Itch and Possibility of a Remittive Effect
Raj Chovatiya, MD, PhD, discusses how approved AD therapeutics currently address itch and whether any therapeutics will eventually have a remittive effect. The article offers valuable insights into the challenges of managing AD in patients.
The Severity of Chronic Itch and Sleep Disturbances in Patients with Atopic Dermatitis
Gil Yosipovitch, MD, addresses the severity of chronic itch and sleep disturbances in patients with atopic dermatitis. The article offers a valuable look at the impact of AD on patients’ quality of life and highlights the need for effective treatment options.
Society for Investigative Dermatology Annual Meeting Highlights
Gottlieb reviews her lecture from the Society for Investigative Dermatology Annual Meeting. The article provides a valuable snapshot of the latest research and developments in dermatology.
The Role of the SDPA in Supporting the Growth and Journeys of PAs
Aubrie Jones, PA-C, MMS, and Laura Bush, DMSc, PA-C, DFAAPA, discuss the role of the SDPA in supporting the growth and journeys of physician assistants at all stages. The article is a must-read for any PA working in dermatology or considering a career in the field.
Tips to Transition Your Clinical Experience to a Different Setting
Terry Arnold, PA-C, shares a wide range of opportunities to take clinical experience to a different setting and tips to transition. The article offers valuable insights for any clinician looking to take their career in a new direction.
Positive Conversations and Reducing Waste in Dermatology
Ethan Sims, MD, spoke with Dermatology Times about having positive conversations, cutting down on waste, and how to get involved in change. The article offers useful insights into how clinicians can make a difference in their practice and in the broader field of dermatology.
Unique Perspectives on Moderate to Severe Plaque Psoriasis Treatment with Tildrakizumab
Omar Noor, MD, and a patient with psoriasis share their unique perspectives on moderate to severe plaque psoriasis treatment with tildrakizumab. The article is a fascinating look at the patient experience and the importance of tailored treatment.
New and Upcoming Medications and Addressing Unmet Needs in Dermatology
Rob Casquejo, PA-C, spoke with Dermatology Times on new and upcoming medications, addressing unmet needs, and social media misinformation. The article provides valuable insights into the latest developments in dermatology and how clinicians can stay up-to-date with the latest research.
Finding a Dermatologist Who Understands the Burden of AD
Eli Lilly recently hosted a panel discussion with Olympic athlete Suni Lee to discuss the importance of finding a dermatologist who understands the burden of AD. The article is particularly useful for patients with AD who are looking for a dermatologist who can provide the best possible care.
Efficacy of 1927 and 1550 Nanometer Lasers to Prevent Skin Cancers
Patricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers. The article provides valuable insights into the latest advancements in laser therapies for skin cancer prevention.
Reflections on Term as SDPA President and Future of Dermatology PAs in Health Care
Laura Bush reflects on her term as SDPA president, discussing achievements, challenges, and the future of dermatology PAs in health care. The article is a must-read for any PA working in dermatology or considering a career in the field.
Potential Risks Associated With Manipulation of Nails and Hygiene and When It Is Necessary to See a Specialist
The recent news of counterfeit Botox resulted in patients with blurred vision, difficulty swallowing, shortness of breath, and additional symptoms. Martin Zaiac, MD, gave insight on potential risks associated with manipulation of nails, hygiene, and when it is necessary to see a specialist. The article is a valuable resource for anyone looking to understand the risks associated with these procedures and how to avoid them.
Next Steps for Oral Treatment After the Completion of Phase 1b Enrollment and Antimicrobial Resistance
Stefan Weiss, MD, MBA, explains next steps for the oral treatment after the completion of phase 1b enrollment, and Stephen Tyring, MD, PhD, MBA, covers the burden of antimicrobial resistance and the need for alternative treatments. The article provides valuable insights into the latest research and developments in dermatology.
Gr
Originally Post From https://www.dermatologytimes.com/view/interview-intersection-expert-interviews-from-june-2024
Read more about this topic at
Conducting Expert Interviews: 10 Easy Steps for Marketing …
How to conduct expert interviews | Articles
